Benzodiazepine
Pregnancy: D
Lorazepam (Elderly — Short-Term Use)
Brand names: Ativan
Adult dose
Dose: 0.5–1 mg once to twice daily (elderly); 1–2 mg (standard adult); IM/IV: 0.05–0.1 mg/kg for acute agitation
Route: oral, IM, IV
Frequency: once to twice daily (maximum 4 weeks oral)
Max: 4 mg/day
In elderly: start 0.5 mg; no active metabolites (preferred over diazepam in elderly); strict 2–4 week maximum for insomnia/anxiety
Paediatric dose
Dose: 0.05 mg/kg
Route: IV or IM
Frequency: single dose or repeat after 10 min
Max: 4 mg single dose
Concentration: 2 mg/mL or 4 mg/mL injection mg/ml
Status epilepticus: 0.1 mg/kg IV (max 4 mg); repeat once if no response at 10 min; dilute 1:1 with saline before IV administration
Dose adjustments
Renal
Use with caution; accumulation possible in renal failure
Hepatic
Reduce dose in severe hepatic impairment
Paediatric weight-based calculator
Status epilepticus: 0.1 mg/kg IV (max 4 mg); repeat once if no response at 10 min; dilute 1:1 with saline before IV administration
Clinical pearls
- No hepatic metabolism to active metabolites — safer in hepatic impairment than diazepam
- STOPP/START criteria and BEERS: avoid >4 weeks — risk of falls, cognitive impairment, dependence
- Opioid + benzodiazepine combination: 3.86x increased risk of overdose death — FDA black box
Contraindications
- Respiratory depression
- Sleep apnoea
- Myasthenia gravis
- Severe hepatic impairment
Side effects
- Sedation
- Falls (major concern in elderly)
- Dependence/withdrawal
- Paradoxical agitation (elderly)
- Amnesia
- Respiratory depression
Interactions
- CNS depressants/alcohol (profound sedation)
- Opioids (respiratory depression — black box warning)
- Valproate (increases lorazepam levels)
Monitoring
- Sedation level
- Falls assessment
- Dependence signs on review
- Respiratory rate
Reference: BNFc; BNF 86; NICE NG11; STOPP/START version 3. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Benzodiazepine Conversion Calculator · Drug Conversion
- Berg Balance Scale (BBS) · Rehabilitation
Drugs
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5